132 related articles for article (PubMed ID: 7720944)
1. Screening of the mutations in luteinizing hormone beta-subunit in patients with menstrual disorders.
Suganuma N; Furui K; Furuhashi M; Asada Y; Kikkawa F; Tomoda Y
Fertil Steril; 1995 May; 63(5):989-95. PubMed ID: 7720944
[TBL] [Abstract][Full Text] [Related]
2. Association of molecular variants of luteinizing hormone with menstrual disorders.
Ramanujam LN; Liao WX; Roy AC; Loganath A; Goh HH; Ng SC
Clin Endocrinol (Oxf); 1999 Aug; 51(2):243-6. PubMed ID: 10468997
[TBL] [Abstract][Full Text] [Related]
3. Role of the mutations Trp8 => Arg and Ile15 => Thr of the human luteinizing hormone beta-subunit in women with polycystic ovary syndrome.
Elter K; Erel CT; Cine N; Ozbek U; Hacihanefioglu B; Ertungealp E
Fertil Steril; 1999 Mar; 71(3):425-30. PubMed ID: 10065776
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic difficulty in polycystic ovary syndrome due to an LH-beta-subunit variant.
Kurioka H; Takahashi K; Irikoma M; Okada M; Ozaki T; Ueda T; Miyazaki K
Eur J Endocrinol; 1999 Mar; 140(3):235-8. PubMed ID: 10216519
[TBL] [Abstract][Full Text] [Related]
5. Pituitary response to luteinizing hormone-releasing hormone in women with variant luteinizing hormone.
Takahashi K; Kurioka H; Ozaki T; Kanasaki H; Miyazaki K; Karino K
Eur J Endocrinol; 2000 Sep; 143(3):375-81. PubMed ID: 11022180
[TBL] [Abstract][Full Text] [Related]
6. A new molecular variant of luteinizing hormone associated with female infertility.
Liao WX; Roy AC; Chan C; Arulkumaran S; Ratnam SS
Fertil Steril; 1998 Jan; 69(1):102-6. PubMed ID: 9457942
[TBL] [Abstract][Full Text] [Related]
7. Identification of two point mutations in the gene coding luteinizing hormone (LH) beta-subunit, associated with immunologically anomalous LH variants.
Furui K; Suganuma N; Tsukahara S; Asada Y; Kikkawa F; Tanaka M; Ozawa T; Tomoda Y
J Clin Endocrinol Metab; 1994 Jan; 78(1):107-13. PubMed ID: 7904610
[TBL] [Abstract][Full Text] [Related]
8. FSHB -211 G>T is a major genetic modulator of reproductive physiology and health in childbearing age women.
Rull K; Grigorova M; Ehrenberg A; Vaas P; Sekavin A; Nõmmemees D; Adler M; Hanson E; Juhanson P; Laan M
Hum Reprod; 2018 May; 33(5):954-966. PubMed ID: 29617818
[TBL] [Abstract][Full Text] [Related]
9. Subcutaneous administration of pulsatile gonadotropin-releasing hormone decreases serum follicle-stimulating hormone and luteinizing hormone levels in women with polycystic ovary syndrome: a preliminary study.
Graña-Barcia M; Liz-Lestón J; Lado-Abeal J
Fertil Steril; 2005 May; 83(5):1466-72. PubMed ID: 15866586
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the effects of ovarian cauterization and gonadotropin-releasing hormone agonist and oral contraceptive therapy combination on endocrine changes in women with polycystic ovary disease.
Taskin O; Yalcinoglu AI; Kafkasli A; Burak F; Ozekici U
Fertil Steril; 1996 Jun; 65(6):1115-8. PubMed ID: 8641482
[TBL] [Abstract][Full Text] [Related]
11. Factors influencing the dynamics of gonadotropin response following bolus infusion of luteinizing hormone-releasing factor in women with menstrual abnormalities.
Cantor B; Kalra PS; Buhi WC; Birk SA; Spellacy WN
Fertil Steril; 1977 May; 28(5):526-30. PubMed ID: 323072
[TBL] [Abstract][Full Text] [Related]
12. Serum bioactive and immunoreactive luteinizing hormone and follicle-stimulating hormone levels in women with cycle abnormalities, with or without polycystic ovarian disease.
Fauser BC; Pache TD; Lamberts SW; Hop WC; de Jong FH; Dahl KD
J Clin Endocrinol Metab; 1991 Oct; 73(4):811-7. PubMed ID: 1909705
[TBL] [Abstract][Full Text] [Related]
13. Prolactin response after gonadotropin-releasing hormone in the polycystic ovary syndrome.
Shoupe D; Lobo RA
Fertil Steril; 1985 Apr; 43(4):549-53. PubMed ID: 3921411
[TBL] [Abstract][Full Text] [Related]
14. Recovery of hormone secretion after chronic gonadotropin-releasing hormone agonist administration in women with polycystic ovarian disease.
de Ziegler D; Steingold K; Cedars M; Lu JK; Meldrum DR; Judd HL; Chang RJ
J Clin Endocrinol Metab; 1989 Jun; 68(6):1111-7. PubMed ID: 2524501
[TBL] [Abstract][Full Text] [Related]
15. LH levels in women with polycystic ovarian syndrome: have modern assays made them irrelevant?
Milsom SR; Sowter MC; Carter MA; Knox BS; Gunn AJ
BJOG; 2003 Aug; 110(8):760-4. PubMed ID: 12892688
[TBL] [Abstract][Full Text] [Related]
16. The utility of the gonadotrophin releasing hormone (GnRH) test in the diagnosis of polycystic ovary syndrome (PCOS).
Lewandowski KC; Cajdler-Łuba A; Salata I; Bieńkiewicz M; Lewiński A
Endokrynol Pol; 2011; 62(2):120-8. PubMed ID: 21528473
[TBL] [Abstract][Full Text] [Related]
17. Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follice-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels.
Reyes FI; Winter JS; Faiman C
Am J Obstet Gynecol; 1977 Nov; 129(5):557-64. PubMed ID: 910845
[TBL] [Abstract][Full Text] [Related]
18. Acute effects of bromocriptine on gonadotropin secretion in polycystic ovary syndrome.
Buvat J; Buvat-Herbaut M; Marcolin G; Racadot A; Fourlinnie JC; Fossati P
Fertil Steril; 1985 Sep; 44(3):356-60. PubMed ID: 3161758
[TBL] [Abstract][Full Text] [Related]
19. Inherited disorders of the gonadotropin hormones.
Jameson JL
Mol Cell Endocrinol; 1996 Dec; 125(1-2):143-9. PubMed ID: 9027352
[TBL] [Abstract][Full Text] [Related]
20. Plasma follicle-stimulating and luteinizing hormones and the macrosopic characteristics of the ovaries in patients with stein-leventhal syndrome. Response to LH-RH in Stein-Leventhal syndrome.
Valkov IM; Dokumov I
Endocrinologie; 1977; 15(1):55-8. PubMed ID: 322249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
